Follow The Filings

IBRX ImmunityBio

ImmunityBio earnings company data as of 7:49 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by IBRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IBRX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $9.5M sold by 3 insiders under 10b5-1 plans
  1. Barry J. Simon Director
    Planned sale
    $269K 25,000 shares at $10.75 0.9% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  2. Cheryl Cohen Director
    Planned sale
    $851K 81,056 shares at $10.50 45% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  3. Christobel Selecky Director
    Planned sale
    $1.4M 159,478 shares at $9.02 100% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  4. Cheryl Cohen Director
    Planned sale
    $1.2M 131,210 shares at $9.50 51% of stake
    Traded Jul 2 Filed Jul 6
    ↗
  5. Christobel Selecky Director
    Planned sale
    $871K 96,722 shares at $9.01 100% of stake
    Traded Jun 29–30 Filed Jul 1
    ↗
  6. Barry J. Simon Director
    Planned sale
    $197K 25,000 shares at $7.88 0.9% of stake
    Traded Jun 24 Filed Jun 26
    ↗
  7. Barry J. Simon Director
    Planned sale
    $165K 23,033 shares at $7.18 0.8% of stake
    Traded Jun 4 Filed Jun 5
    ↗
  8. Barry J. Simon Director
    Planned sale
    $901K 75,000 shares at $12.01 2.6% of stake
    Traded Feb 24 Filed Feb 26
    ↗
  9. Christobel Selecky Director
    Planned sale
    $250K 25,000 shares at $10.00 100% of stake
    Traded Feb 23 Filed Feb 24
    ↗
  10. Barry J. Simon Director
    Planned sale
    $1.8M 175,000 shares at $10.19 5.6% of stake
    Traded Feb 20–23 Filed Feb 24
    ↗
  11. Christobel Selecky Director
    Planned sale
    $438K 75,000 shares at $5.84 100% of stake
    Traded Jan 16–20 Filed Jan 21
    ↗
  12. Barry J. Simon Director
    Planned sale
    $1.1M 151,967 shares at $7.20 4.7% of stake
    Traded Jan 20 Filed Jan 21
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 option exercises, 11 share withholdings for taxes, and 1 conversion.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,2.03,7.01,8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.